Hm Payson & CO Bridge Bio Pharma, Inc. Transaction History
Hm Payson & CO
- $5.6 Billion
- Q1 2025
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$1.01 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$900 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$724 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$680 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$507 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...